Skip to main content

Diagnostic options · UAE

Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 76–90 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5429
DLX3 Gene Sequencing Test for Amelogenesis Imperfecta Type 4

This test evaluates the DLX3 gene for pathogenic variants associated with Amelogenesis Imperfecta Type 4 (AI4) and Tricho-Dento-Osseous (TDO) syndrome.

Whole blood (EDTA), extracted DNA, dried FTA card, buccal swab 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in DLX3 gene coding exons", "Intron-exon boundaries of DLX3 gene", "Copy Number Variations (CNVs) in DLX3 gene"]
Parameters
[]
Preparation
["No special preparation, fasting, or medication changes are required."]
Indications
["Suspected diagnosis of Amelogenesis Imperfecta Type 4 (AI4)", "Suspected diagnosis of Tricho-Dento-Osseous (TDO) syndrome", "Family history of AI4 or TDO syndrome", "Need for definitive molecular diagnosis of hereditary enamel defects"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88715-7 ICD-10: K00.5
Clinical summary
This test evaluates the DLX3 gene for pathogenic variants associated with Amelogenesis Imperfecta Type 4 (AI4) and Tricho-Dento-Osseous (TDO) syndrome.
TEST-5930
DNAJC19 Gene (3‑Methylglutaconic Aciduria Type 5) Genetic Test

This test identifies pathogenic variants in the DNAJC19 gene associated with 3-methylglutaconic aciduria type 5.

Peripheral blood, Extracted DNA, or FTA card (dried blood spot) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DNAJC19 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist about blood thinners or bleeding disorders"]
Indications
["Suspected 3-methylglutaconic aciduria type 5", "Family history of mitochondrial disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 80866-8 ICD-10: E71.115
Clinical summary
This test identifies pathogenic variants in the DNAJC19 gene associated with 3-methylglutaconic aciduria type 5.
TEST-5519
DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test

This genetic test analyzes the DNAL1 gene to identify mutations associated with primary ciliary dyskinesia type 16.

Peripheral Whole Blood (or extracted DNA / FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DNAL1 gene sequence", "Mutations within the DNAL1 coding region"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected primary ciliary dyskinesia", "Family history of PCD", "Chronic respiratory infections unresponsive to standard treatment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-1 ICD-10: J98.09
Clinical summary
This genetic test analyzes the DNAL1 gene to identify mutations associated with primary ciliary dyskinesia type 16.
TEST-4547
DNASE1 Gene Systemic Lupus Erythematosus Genetic Test

This test identifies pathogenic mutations in the DNASE1 gene, which are associated with a specific form of monogenic Systemic Lupus Erythematosus (SLE).

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the DNASE1 gene", "Single-nucleotide variants", "Small insertions and deletions"]
Parameters
[]
Preparation
[]
Indications
["Suspected monogenic Systemic Lupus Erythematosus (SLE)", "Differentiation between monogenic and polygenic lupus", "Guidance for immunosuppressive therapy", "Family risk evaluation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81265-1 ICD-10: M32.9
Clinical summary
This test identifies pathogenic mutations in the DNASE1 gene, which are associated with a specific form of monogenic Systemic Lupus Erythematosus (SLE).
TEST-4876
DNMT3B Gene Immunodeficiency‑Centromeric Instability‑Facial Anomalies Syndrome Type 1 Genetic Test

This genetic test analyzes the DNMT3B gene to detect mutations associated with Immunodeficiency‑Centromeric Instability‑Facial Anomalies Syndrome Type 1 (ICF1). It identifies point...

Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DNMT3B gene sequence", "Point mutations", "Small insertions/deletions (indels)", "Copy number variants"]
Parameters
[{"name": "DNMT3B Exon Coverage", "reference_range": "100% coverage of all DNMT3B exons"}, {"name": "Base-Level Accuracy", "reference_range": ">99.9%"}]
Preparation
["No fasting required", "Inform lab of any recent blood transfusions (< 4 weeks)", "Inform lab of known haematologic malignancy"]
Indications
["Suspected Immunodeficiency‑Centromeric Instability‑Facial Anomalies Syndrome Type 1 (ICF1)", "Family history of ICF1", "Clinical features consistent with ICF1"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81261-6 ICD-10: D81.8, Q87.8
Clinical summary
This genetic test analyzes the DNMT3B gene to detect mutations associated with Immunodeficiency‑Centromeric Instability‑Facial Anomalies Syndrome Type 1 (ICF1). It identifies point mutations, small indels, and copy-number variants within the gene.
TEST-4919
DOCK8 Gene Mental Retardation, Autosomal Dominant Type 2 Genetic Test

This test detects pathogenic variants in the DOCK8 gene associated with autosomal dominant intellectual disability type 2.

Whole Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DOCK8 gene", "Single nucleotide variants", "Small indels"]
Parameters
[]
Preparation
["Clinical history + genetic counselling session (pedigree chart)"]
Indications
["Individuals with unexplained intellectual disability", "Individuals with developmental delay", "Family history suggestive of autosomal dominant inheritance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 31208-2 ICD-10: Q87.8
Clinical summary
This test detects pathogenic variants in the DOCK8 gene associated with autosomal dominant intellectual disability type 2.
TEST-4542
DOLK Gene (Glycosylation Disorder Type 1M) Genetic Test

This test identifies pathogenic variants in the DOLK gene associated with Congenital Disorder of Glycosylation Type 1M (CDG-Im).

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DOLK gene sequence", "Pathogenic variants", "Likely pathogenic variants"]
Parameters
[]
Preparation
[]
Indications
["Unexplained developmental delay", "Failure to thrive", "Seizures", "Coagulopathy", "Elevated liver enzymes", "Inverted nipples", "Abnormal fat pads", "Family history of CDG", "Biochemical screening suggesting glycosylation defect"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51966-8 ICD-10: E77.8
Clinical summary
This test identifies pathogenic variants in the DOLK gene associated with Congenital Disorder of Glycosylation Type 1M (CDG-Im).
TEST-5089
DSG1 Gene Sequencing (Erythroderma, Palmoplantar Keratoderma, Hypotrichosis, Hyper-IgE Syndrome) Test

This test evaluates the DSG1 gene for pathogenic variants associated with a rare autosomal recessive syndrome.

Whole Blood (EDTA) or Buccal Swab 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DSG1 gene sequence", "Pathogenic mutations in DSG1"]
Parameters
[]
Preparation
["Inform phlebotomist of all current medications, especially anticoagulants.", "A buccal swab may be used if blood collection is contraindicated."]
Indications
["Diagnosis of DSG1-related syndrome", "Evaluation of individuals with suggestive clinical features"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94887-6 ICD-10: Q80.9
Clinical summary
This test evaluates the DSG1 gene for pathogenic variants associated with a rare autosomal recessive syndrome.
TEST-5753
DSPP Gene (Deafness, Autosomal Dominant Type 39 with Dentinogenesis Type I) Genetic Test

This genetic test identifies pathogenic variants in the DSPP gene, confirming the diagnosis of autosomal dominant deafness type 39 with dentinogenesis imperfecta type I.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DSPP gene", "Full coding region and conserved splice sites"]
Parameters
[]
Preparation
["Pre-Test Genetic Counselling Recommended", "Informed consent discussing autosomal dominant inheritance, penetrance, and implications for first-degree relatives is mandatory"]
Indications
["Individuals with sensorineural hearing loss and dental enamel hypoplasia or dentinogenesis imperfecta", "Family history suggesting autosomal dominant inheritance", "At-risk relatives of known DSPP variant carriers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100374-6 ICD-10: H90.3, K00.5, Z13.71
Clinical summary
This genetic test identifies pathogenic variants in the DSPP gene, confirming the diagnosis of autosomal dominant deafness type 39 with dentinogenesis imperfecta type I.
TEST-4549
DYM Gene Smith‑McCort Dysplasia Genetic Test (NGS)

This genetic test sequences the DYM gene to identify pathogenic variants associated with Smith-McCort dysplasia.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DYM gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected Smith-McCort dysplasia", "Skeletal dysplasia", "Family history of SMC", "Prenatal testing if parents are known carriers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94091-7 ICD-10: Q77.2
Clinical summary
This genetic test sequences the DYM gene to identify pathogenic variants associated with Smith-McCort dysplasia.
TEST-2592
DYNC1H1 Gene Intellectual Disability, Autosomal Dominant Type 13 Genetic Test

This genetic test identifies pathogenic variants within the DYNC1H1 gene associated with Autosomal Dominant Intellectual Disability Type 13.

Peripheral whole blood (3 mL EDTA) or dried blood spot (FTA card) 3 to 4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DYNC1H1 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number changes"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet changes needed"]
Indications
["Clinical suspicion of Autosomal Dominant Intellectual Disability Type 13", "Confirmed family history of DYNC1H1-related disorders", "Genetic counselling for reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-5 ICD-10: F79, Z13.79, Z14.8
Clinical summary
This genetic test identifies pathogenic variants within the DYNC1H1 gene associated with Autosomal Dominant Intellectual Disability Type 13.
TEST-2322
DYNC2H1 Gene Sequencing for Short-Rib Thoracic Dysplasia Type 3 (With or Without Polydactyly) Test

This diagnostic test evaluates the DYNC2H1 gene for pathogenic variants associated with short-rib thoracic dysplasia type 3 (SRTD3).

Whole Blood (peripheral) or Buccal Swab 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DYNC2H1 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number alterations"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Suspected diagnosis of short-rib thoracic dysplasia type 3 (SRTD3)", "Family history of SRTD3", "Neonatal respiratory distress with skeletal abnormalities"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94854-3 ICD-10: Q77.2
Clinical summary
This diagnostic test evaluates the DYNC2H1 gene for pathogenic variants associated with short-rib thoracic dysplasia type 3 (SRTD3).
TEST-5330
EBP Gene Chondrodysplasia Punctata (CDPX2) Genetic Test

This genetic test identifies pathogenic variants in the EBP gene, confirming X-linked dominant chondrodysplasia punctata.

Whole Blood (EDTA) or FTA Card Dried Blood Spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EBP gene", "Copy number variations in the EBP gene"]
Parameters
[]
Preparation
["No fasting required", "Provide 3–5 mL whole blood in an EDTA tube or FTA card"]
Indications
["Suspected X-linked dominant chondrodysplasia punctata", "Management of asymmetric skeletal anomalies", "Management of ichthyosiform skin changes", "Management of developmental delay"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: Q77.3
Clinical summary
This genetic test identifies pathogenic variants in the EBP gene, confirming X-linked dominant chondrodysplasia punctata.
TEST-4840
EEF1A2 Gene (Autosomal Dominant Intellectual Disability Type 38) Next-Generation Sequencing Genetic Test

This test identifies pathogenic variants in the EEF1A2 gene associated with autosomal dominant intellectual disability type 38.

Whole blood (EDTA tube), extracted DNA, or FTA card (dried blood spot) 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EEF1A2 gene", "Single-nucleotide changes", "Indels", "Splice variants"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Moderate to severe developmental delay", "Intellectual disability", "Family history consistent with autosomal dominant transmission", "Normal chromosomal microarray", "Normal metabolic screen"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: F79.9
Clinical summary
This test identifies pathogenic variants in the EEF1A2 gene associated with autosomal dominant intellectual disability type 38.
TEST-3624
EFEMP1 Gene Doyne Honeycomb Retinal Dystrophy Genetic Test

This genetic test evaluates the EFEMP1 gene for pathogenic variants associated with Doyne Honeycomb Retinal Dystrophy.

Peripheral whole blood (EDTA) or saliva 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EFEMP1 gene", "Presence of mutations causing Doyne Honeycomb Retinal Dystrophy"]
Parameters
[{"name": "Analytical Sensitivity", "reference_range": "99.9%"}, {"name": "Coverage", "reference_range": "All exons & splice sites"}]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected Doyne Honeycomb Retinal Dystrophy", "Family history of Doyne Honeycomb Retinal Dystrophy", "Genetic counselling for inherited retinal diseases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81273-5 ICD-10: H35.54
Clinical summary
This genetic test evaluates the EFEMP1 gene for pathogenic variants associated with Doyne Honeycomb Retinal Dystrophy.

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.